Properties of a new radioiodinated antagonist for human vasopressin V-2 and V-1a receptors

被引:21
作者
Ala, Y
Morin, D
Mahe, E
Cotte, N
Mouillac, B
Jard, S
Barberis, C
Tribollet, E
Dreifuss, JJ
Sawyer, WH
Wo, NC
Chan, WY
Kolodziejczyk, AS
Cheng, LL
Manning, M
机构
[1] CNRS, INSERM, CTR PHARMACOL ENDOCRINOL, UNITE INSERM 469, F-34094 MONTPELLIER 05, FRANCE
[2] MED UNIV, DEPT PHYSIOL, GENEVA, SWITZERLAND
[3] COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA
[4] CORNELL UNIV MED COLL, NEW YORK, NY USA
[5] MED COLL OHIO, TOLEDO, OH 43699 USA
关键词
vasopressin V-2 receptor; human; vasopressin receptor antagonist; iodinated; autoradiography;
D O I
10.1016/S0014-2999(97)01021-2
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A vasopressin receptor antagonist, [1-(beta-mercapto-beta,beta-pentamethylenepropionic acid), 2-O-ethyl-D-tyrosine, 4-valine, 9-tyrosylamide] arginine vasopressin (d(CH2)(5)[o-ethyl-D-Tyr(2),Tyr-NH29]AVP), has been prepared. This antagonist is a potent antiantidiuretic, antivasopressor and antioxytocic peptide with pA(2) values of 7.69-7.94 and affinities of 1.12-11.0 nM. When radioiodinated at the phenyl moiety of the tyrosylamide residue at position 9, this peptide was demonstrated to bind to vasopressin V-2 and V-1a receptors with a dissociation constant of 0.22-0.75 nM. This ligand is a good tool for further studies on human vasopressin V, receptor localization and characterization, when used in combination with a selective vasopressin V-1a ligand. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 39 条
[1]  
Allison NL, 1988, VASOPRESSIN CELLULAR, P207
[2]   CHARACTERIZATION OF A NOVEL, LINEAR RADIOIODINATED VASOPRESSIN ANTAGONIST - AN EXCELLENT RADIOLIGAND FOR VASOPRESSIN V-1A RECEPTORS [J].
BARBERIS, C ;
BALESTRE, MN ;
JARD, S ;
TRIBOLLET, E ;
ARSENIJEVIC, Y ;
DREIFUSS, JJ ;
BANKOWSKI, K ;
MANNING, M ;
CHAN, WY ;
SCHLOSSER, SS ;
HOLSBOER, F ;
ELANDS, J .
NEUROENDOCRINOLOGY, 1995, 62 (02) :135-146
[3]   LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS [J].
BERRIDGE, MJ ;
DOWNES, CP ;
HANLEY, MR .
BIOCHEMICAL JOURNAL, 1982, 206 (03) :587-595
[4]   MOLECULAR-CLONING OF THE RECEPTOR FOR HUMAN ANTIDIURETIC-HORMONE [J].
BIRNBAUMER, M ;
SEIBOLD, A ;
GILBERT, S ;
ISHIDO, M ;
BARBERIS, C ;
ANTARAMIAN, A ;
BRABET, P ;
ROSENTHAL, W .
NATURE, 1992, 357 (6376) :333-335
[5]  
BOCKAERT J, 1973, J BIOL CHEM, V248, P5922
[6]  
BODANSZKY M, 1964, CHEM IND-LONDON, P1423
[7]   TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR [J].
CHINI, B ;
MOUILLAC, B ;
ALA, Y ;
BALESTRE, MN ;
TRUMPPKALLMEYER, S ;
HOFLACK, J ;
ELANDS, J ;
HIBERT, M ;
MANNING, M ;
JARD, S ;
BARBERIS, C .
EMBO JOURNAL, 1995, 14 (10) :2176-2182
[8]   THE QUANTITATIVE ASSAY OF VASOPRESSIN [J].
DEKANSKI, J .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1952, 7 (04) :567-572
[9]   I-125-LABELED D(CH2)5[TYR(ME)2,THR4,TYR-NH2(9)]OVT - A SELECTIVE OXYTOCIN RECEPTOR LIGAND [J].
ELANDS, J ;
BARBERIS, C ;
JARD, S ;
TRIBOLLET, E ;
DREIFUSS, JJ ;
BANKOWSKI, K ;
MANNING, M ;
SAWYER, WH .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 147 (02) :197-207
[10]   KINETIC AND PHARMACOLOGICAL CHARACTERIZATION OF VASOPRESSIN MEMBRANE-RECEPTORS FROM HUMAN-KIDNEY MEDULLA - RELATION TO ADENYLATE-CYCLASE ACTIVATION [J].
GUILLON, G ;
BUTLEN, D ;
CANTAU, B ;
BARTH, T ;
JARD, S .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 85 (3-4) :291-304